Skip to main navigation Skip to search Skip to main content

Verapamil-induced secondary erythermalgia

  • J. P. H. Drenth
  • , J. J. Michiels*
  • , T. van Joost
  • , V. D. Vuzevski
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

A 59-year-old man developed red, swollen and warm feet accompanied by intermittent burning pain during treatment for cardiac failure and arrhythmias with several drugs including verapamil. The condition gradually worsened until there was persistent disabling burning pain and severe erythema and swelling of the feet. Aspirin and other analgesics were ineffective in relieving the discomfort. Histopathology of punch biopsies showed a mild perivascular mononuclear infiltrate and moderate perivascular oedema. Within 2 weeks of stopping verapamil the burning pain, erythema, and swelling of the feet had resolved. The clinical features and subsequent course are consistent with a diagnosis of erythermalgia secondary to verapamil.
Original languageEnglish
Pages (from-to)292-294
JournalBritish journal of dermatology
Volume127
Issue number3
DOIs
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Dive into the research topics of 'Verapamil-induced secondary erythermalgia'. Together they form a unique fingerprint.

Cite this